Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity.
Shoji K, Hikino K, Saito J, Matsui T, Utano T, Takebayashi A, Tomizawa D, Kato M, Matsumoto K, Ishikawa T, Kawai T, Nakamura H, Miyairi I, Terao C, Mushiroda T.
Shoji K, et al. Among authors: miyairi i.
J Infect Chemother. 2024 Dec;30(12):1280-1288. doi: 10.1016/j.jiac.2024.06.009. Epub 2024 Jun 17.
J Infect Chemother. 2024.
PMID: 38897411